Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1

Conditions

Vitamin D Deficiency 1Sarcoma 1Prostatic Neoplasms 1Fractures, Stress 1Disease Progression 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × RNA-Seq × 1 year × Clear all
NCT06751251 2025-07-10

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

Peking University People's Hospital

Active not recruiting
200 enrolled
Sarcoma

Sarcoma, Disease Progression

NCT04621500 2025-07-04

VitD/RNA-seq

Medical University of South Carolina

Phase 2 Completed
60 enrolled 7 charts
Genitourinary

Prostatic Neoplasms, Vitamin D Deficiency, Fractures, Stress

Data powered by HemOnc (CC BY 4.0) Colophon âš¡